Proteomics pursues predictive test for diabetic kidney disease in Asia

Proteomics International, the leader in predictive diagnostics for diabetic kidney disease, will advance deals with commercialisation partners in Singapore and China this week to bring PromarkerD, which is patented in both countries, to the Asian market.

Media release

  • This field is for validation purposes and should be left unchanged.